Whist we seek something better to talk about may I ask how can the company get away with telling the market that a US Neurologist is interested in helping and just leave it at that?
As we drift rather rapidly towards all time lows it is impossible to accept such vagueness from my perspective. The company's entire 1102 future now rests on getting initial free funding. What happens if this falls over?
immature, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
